In Silico Molecular Docking Study for Prediction of Binding Affinities to Penicillin Binding Proteins and β-Lactamases of Amino Acids-Cephalexin conjugates
Keywords:Cephalexin, Amino acids, Molecular docking, PBPs, β-lactamases, Molinspiration calculations, drug-likeness
Cephalexin is a first generation cephalosporin with high antibacterial activity against a number of microbes. Cephalexin is highly sensitive and could be hydrolyzed by almost all of β-lactamases. An in silico prediction and evaluation study is performed to find a possibility of bringing new life to cephalexin, and other cephalosporins that are susceptible to hydrolysis by lactamases. This approach includes an introduction of an amino acid moiety into cephalexin through an amide bond with its primary amine group. This amino acid moiety is expected to provide steric hindrance and protecting the β-lactam ring from being hydrolyzed. In silico study included measurement of binding affinity to penicillin binding proteins (PBPs) and D-alanyl-D-alanine carboxypeptidases and to β-lactamases. Drug likeness and Molinspiration calculations were recorded to find a reliable correlation with better activity and stability against β-lactamases. The newly suggested conjugates that recorded the best score of binding affinity on PBPs are L-Phe-Cephalexin, L-Arg-Cephalexin, L-Tyr-Cephalexin and L-Thr-Cephalexin. Two of these conjugates, namely, L-Arg-Cephalexin and L-Tyr-Cephalexin recorded high binding affinity scores on D-alanyl-D-alanine carboxypeptidases. Moreover, the predicted stability of L-Arg-Cephalexin and L-Tyr-Cephalexin conjugates against β-lactamases was recorded. Drug-Likeness parameters have shown that L-Cys-Cephalexin, L-Lys-Cephalexin and L-Arg-Cephalexin conjugates were the best compounds recording the highest binding affinity. In conclusion, the amino acid-linked cephalexin conjugates were found to possess high binding affinity to PBPs, D-alanyl-D-alanine carboxypeptidases and β-lactamases, which may encourage the synthesis and intensive evaluation.
• Abdel Aziz R. et al., (1997). Synthesis and antimicrobial activity of some penicillin and cephalosporin derivatives. Ind. J. Chemistry Vol. 36B, 1997, pp. 196-198.
• Ana C. Puhl et al., (2022). Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV‑2 Spike Inhibitors; ACS Omega, 7, 27950-58.
• Alwan SM. (2012). Synthesis and Preliminary Antimicrobial Activities of New Arylideneamino-1,3,4-Thiadiazole-(thio/dithio) Acetamido Cephalosporanic Acids. Molecules, 17:1025-38.
• Aruna NT. and Gowrama BS, (2014). biological evaluation of some novel Schiff bases of cephalexin. Int. J. Pharm. Sci., Vol. 5 (3), 1008-1014.
• Australia H, (2012).The thirteenth Biennial Health Report of the Australian Instit. Health and Welfare. Aust. Instit. Health and Welfare. p 408.
• Baig MH. et al., (2014). Insight into the Effect of Inhibitor Resistant S130G Mutant on Physico-Chemical Properties of SHV Type Beta-Lactamase: A Molecular Dynamics Study. PLoS ONE 9(12): e112456. doi:10.1371/journal. Pone. 0112456.
• Dale JW. and Smith JT. (1974). R-Factor-Mediated 3-Lactamases that hydrolyze Oxacillin: evidence for two distinct groups. J. Bacteriology. pp. 351-35.
• Davies TA. et.al., (2007). Binding of Ceftobiprole and comparators to the Penicillin-Binding Proteins of E. coli, P. aeruginosa, Staph. aureus, and Str. pneumonia, Antimicrob. Agents Chemother. 51 (7): 2621-4.
• Drawz SM. and Bonomo RA. (January 2010). Clinical Microbiology Reviews. 23 (1): 160–201. DOI:10.1128/CMR.00037-09. PMC 2806661. PMID 20065329.
• Dunn GL. (1982). Ceftizoxime and other third-generation cephalosporins: structure-activity relationships. J. Antimicrobial. Chemotherapy, 10, Suppl. C, 1-10.
• Ertl P. Rohde B. and Selzer P. (2000). Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and its Application to the Prediction of Drug Transport Properties., J. Med. Chem. 43 (20): 3714-7.
• Fisher JF. Meroueh SO. and Mobashery S. (February 2005). "Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity". Chemical Reviews. 105 (2): 395–424. DOI:10.1021/cr030102i. PMID 15700950.
• Gerber MA. et al., (2009). Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 119:1541-51. [PubMed 19246689].
• Joshi S. et. al., (2011). Antibacterial and antioxidant properties of Mn (II), Co (II), Ni (II) and Zn (II) complex of Schiff bases derived from cephalexin, Res. J. Pharm. Biol. and Chem. Sci.Vol.2 (1), 61-64.
• Kamar A. et al., (1988). Comparative study of cephalexin hydrochloride and cephalexin monohydrate in the treatment of skin and soft tissue infections. Antimicrob. Agents Chemother. 32:882-5. [IDIS 244249], (PubMed; 3046484).
• Lieberthal AS. et. al., (2013). The diagnosis and management of acute otitis media. Pediatrics. 131: e964-99. (PubMed 23439909).
• Lipinski CA, et.al., (2001). Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Stings., Adv. Drug Delivery Rev. 46, (1-3): 3-26.
• Masayasu K. et.al., (1999). AS-924, A novel orally active bifunctional prodrugs of Ceftizoxime. Synthesis and relationship between physicochemical properties and oral absorption. Chem. Pharm. Bull. 47(8) 1081-1088.
• Miyamoto TM. et.al., (Sep.1997). Penicillin-binding protein sensitive to cephalexin in sporulation of Bacillus cereus, Microbiol. Res., 1997, 152(3):227-232. doi: 10.1016/s0944-5013 (97) 80032-8.
• Nyandoro SN. et al., (2018). In silico pharmacokinetic and molecular docking studies of N-Cinnamoyltetraketide derivatives as inhibitors of cyclooxygenase-2 enzyme. Tanzania J. Sci. 44(2): 1-15, ISSN 0856-1761, e-ISSN 2507-7961.
• Oliveira JW. de F. et.al., (2019). Application of Dithiocarbamates as Potential New Anti-Trypanosomatids Drugs: Approach Chemistry, Functional and Biological. 24, 2806.
• Shulman ST. et al., (2012). Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: update by the Infectious Diseases Society of America. Clin. Infect. Dis. 55:1279-82. (PubMed 23091044).
• Spratt BG. and Cromie KD. (Jul-Aug 1988) . Penicillin-binding proteins of gram-negative bacteria. Rev. Infect. Dis.;10(4):699-711. doi: 10.1093/clinids/10.4.699.
• Wilson W. et. al., (2007). Prevention of infective endocarditis. Guidelines from the American Heart Association. A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116:1736-1754 (Circulation is available at http://circ.ahajournals.org.
• Valcavi U. et.al., (1980). Synthesis and antibacterial activity of some ureido cephalexin and cefadroxil derivatives., Farmaco Sci. 35(7), 563-572.
• Vallianatou T, Tsopelas F, Tsantili-Kakoulidou A. (2022). Prediction Models for Brain Distribution of Drugs Based on Biomimetic Chromatographic Data., Molecules. 27(12):3668. doi: 10.3390/molecules27123668.PMID: 35744794.